Management of Contact Dermatitis
The cornerstone of contact dermatitis management is complete avoidance of identified allergens and irritants, combined with skin barrier restoration using emollients and topical corticosteroids for active inflammation. 1, 2
Diagnostic Approach
When to Investigate
Patch testing is essential for any persistent eczematous eruption when contact allergy is suspected or cannot be ruled out, particularly for hand and facial eczema where clinical features alone cannot reliably distinguish allergic from irritant or endogenous causes 1.
Key indications for patch testing include:
- Persistent dermatitis despite standard treatment
- Hand and eyelid involvement
- Occupational exposure history
- Disease aggravated by topical products
- Unusual distribution patterns
- Later onset or new significant worsening 3
Patch Testing Methodology
- Apply standardized allergen concentrations to the back using Finn chambers or preprepared systems (TRUE test, Epiquick)
- Read at day 2 and day 4 (optimal timing), with additional reading at day 6-7 for delayed reactions 1
- Sensitivity and specificity: 70-80% 1
- Avoid testing during active dermatitis on the back ("angry back syndrome" causes false positives) 1
- Hold potent topical steroids for 2 days before testing; systemic steroids ≤10 mg prednisolone daily unlikely to suppress results 1
Treatment Strategy
Irritant Contact Dermatitis
Primary management involves three principles: avoidance, protection, and substitution 1:
Avoidance:
- Identify all potential irritants (soaps, detergents, water, occupational chemicals)
- Workplace visits may be necessary to identify hidden exposures 2
Protection:
- For hands: Use rubber or polyvinyl chloride household gloves with cotton liners
- Remove gloves regularly to prevent occlusion-related barrier impairment
- Occupational settings: Select gloves based on specific chemical exposure and permeation time
- Note: "impervious" gloves have finite protection duration 1
Allergic Contact Dermatitis
Complete allergen avoidance is mandatory 2:
- Provide written information on allergen names, sources, and cross-reactors
- Contact manufacturers to verify product ingredients
- Consider workplace modifications or job reassignment if severe
- Personal protective equipment less effective for potent sensitizers and airborne allergens 2
Pharmacological Treatment
For localized acute lesions:
- Mid- to high-potency topical corticosteroids (triamcinolone 0.1% or clobetasol 0.05%) 4
- Relief typically within 12-24 hours
For extensive involvement (>20% body surface area):
- Systemic corticosteroids required 4
- For severe rhus (poison ivy) dermatitis: oral prednisone tapered over 2-3 weeks
- Critical: Rapid discontinuation causes rebound dermatitis 4
Adjunctive therapy:
- Emollients to restore skin barrier 5
- Antihistamines for symptom relief
- Systemic immunosuppressants for refractory cases 5
Common Pitfalls
Inadequate steroid duration: Tapering too quickly leads to rebound, especially with extensive allergic contact dermatitis 4
Missed allergens: Common culprits include methylisothiazolinone, nickel, formaldehyde, quaternium-15, fragrance mix I, and rubber accelerators (healthcare workers) 6
False negatives on patch testing: Caused by concurrent systemic steroids >10 mg/day or recent potent topical steroid use 1
Overlooking occupational factors: Workplace visits identify hidden exposures and contamination sources 2
Incomplete allergen avoidance: Patients must know all product names and cross-reactors; only 17% remember allergen names after 10 years despite 79% remembering they tested positive 2
Special Considerations
Occupational contact dermatitis: Changing occupation is last resort; early diagnosis allows retraining (e.g., hairdressers with severe disease) 2
Children: Increasing reports of allergic contact dermatitis; test those with hand and eyelid eczema for nickel, topical antibiotics, preservatives, fragrances, and rubber accelerators 1
Prognosis: Allergic dermatitis carries worse prognosis than irritant dermatitis unless allergen identified and avoided; chronicity most common with nickel and chromate allergy 1